Skip to content
Dendreon
  • News
  • Contact Us
  • About
  • Science and Services
    • Cellular Therapy Manufacturing
    • Provenge Immunotherapy
  • Publications
  • Careers
Demonstration of PROVENGE-Activated Immune Cells Killing Other Cells that Have Prostate Cancer Antigens in vitro
February 25, 2021

Demonstration of PROVENGE-Activated Immune Cells Killing Other Cells that Have Prostate Cancer Antigens in vitro

  • Topics: Clinical Study, How Provenge Works, Phase 2, Post Hoc STAND
  • Published In: Journal of the National Cancer Institute
Read the Full article
LinkedInShareTweet
Dendreon
© Dendreon Pharmaceuticals LLC. All Rights Reserved. 2023.
  • Privacy Policy
  • Legal Notice
  • Site Map
  • Linkedin
  • Facebook
  • Twitter